Daniel Catenacci completed his MD at the age of 27 years from Wayne State University School of Medicine, Detroit Michigan. He completed an Internal Medicine Residency at UCLA Medical Center, Westwood, Los Angeles. He completed his Hematology/Oncology Fellowship at the University of Chicago Medical Center. As an adult medical oncologist, Dr. Catenacci, specializes in the treatment of gastrointestinal malignancies. An active basic and clinical researcher, Dr. Catenacci is involved in bench-to-bedside translational research. He conducts basic investigations on normal and cancer cell signaling with the ultimate goal of developing new inhibitory drugs for the treatment of gastroesophageal cancer. Daniel Catenacci completed his MD at the age of 27 years from Wayne State University School of Medicine, Detroit Michigan. He completed an Internal Medicine Residency at UCLA Medical Center, Westwood, Los Angeles. He completed his Hematology/Oncology Fellowship at the University of Chicago Medical Center. As an adult medical oncologist, Dr. Catenacci, specializes in the treatment of gastrointestinal malignancies. An active basic and clinical researcher, Dr. Catenacci is involved in bench-to-bedside translational research. He conducts basic investigations on normal and cancer cell signaling with the ultimate goal of developing new inhibitory drugs for the treatment of gastroesophageal cancer.

Gastroenterology